[1]
Epstein, BS, H., Perez-Correa, MD, A., Beltre, BS, J., Fitzsimmons, ASN, C., Marcus, BA, P., Ramirez, BA, F., Stern, RN, MPH, L.S., Norton, DO, MPH, B.L., Fox, MD, MS, A.D. and Jakubowski, MD, MS, A. 2021. Interest in long-acting injectable buprenorphine among syringe services program participants. Journal of Opioid Management. 17, 7 (Aug. 2021), 59–67. DOI:https://doi.org/10.5055/jom.2021.0643.